Quantcast

REIT Bloodbath: Why Now Is The Time To Buy These 2 High-Yield REIT Blue Chips

Posted On October 31, 2016 4:08 pm
By:

REITs have had a rough few months, falling over 12%. Find out why two high-yield, grade A, medical REITs in particular are now undervalued, and more importantly why you should take this market opportunity to add them to your own portfolio.

Continue Reading Here

About author

Dividend Sensei
Dividend Sensei

I’m an Army veteran and former energy dividend writer for The Motley Fool. I currently write for both Seeking Alpha, Simply Safe Dividends, Investorplace.com, and TheStreet.com.

My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 20 years of investing experience, I’ve learned what works and more importantly, what doesn’t, when it comes to building long-term wealth and income streams. I’m currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that:

1. Pays a 4% to 5% yield
2. Offers 9% to 10% annual dividend growth
3. Pays dividends AT LEAST on a weekly, but preferably, daily basis

Related Articles